Navigating the Future: Bioengineering Technology Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Bioengineering Technology Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a swift expansion in the size of the bioengineering technology market. Expected to surge from $320.38 billion in 2024 to $361.95 billion in 2025, it will exhibit a compound annual growth rate (CAGR) of 13.0%. Factors contributing to the growth witnessed in the historic period include an escalating aging population, a rise in chronic diseases prevalence, expansion of the bioengineering technology market, beneficial government policies, and the progression of genetic engineering strategies.

How Will the Bioengineering Technology Market Size Evolve and Grow by 2029?
In the forthcoming years, the bioengineering technology market is anticipated to witness a fast-paced expansion. It is projected to swell to a value of $591.25 billion by 2029, at a compound annual growth rate (CAGR) of 13.1%. This surge during the forecast period is likely due to factors such as a growing emphasis on cell therapies, the quick advancement of synthetic biology, improvements in precision medicine, an increased usage in agriculture, and a widened application in environmental solutions. Dominant trends projected for this forecast period consist of superior gene editing methodologies, technological amalgamation, progression in precision medicine, global cooperation and partnerships, and applications of synthetic biology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bioengineering-technology-global-market-report

What Drivers Are Propelling the Growth of Bioengineering Technology Market Forward?
The growth of the bioengineering technology market is predicted to be propelled by the rising prevalence of chronic diseases. Chronic diseases are long-term health conditions known for their extended and continuous characteristics. Bioengineering technology plays a crucial role in the management and treatment of these diseases due to its ability to offer inventive solutions, enhanced outcomes, and to improve the quality of life of patients. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported the age-standardized death rate associated with chronic conditions was 448 per 100,000 population. This figure slightly increased to 459 per 100,000 in 2021, and escalated further to 490 per 100,000 in 2022. Thus, the rising incidence of chronic diseases is fueling the expansion of the bioengineering technology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13609&type=smp

Which Emerging Trends Are Transforming the Bioengineering Technology Market in 2025?
Prominent businesses active in the bioengineering technology sector are focusing their efforts on creating breakthrough products such as Mito Plus, in order to push the boundaries of regenerative medicine. Mito Plus is a groundbreaking 3D bioprinter, entirely developed within the country. This device works by generating organs or tissues similar to those naturally found in the body, made up of living cells, via 3D printing technologies. For example, in November 2022, Mito Plus was launched by Avay Biosciences Pvt. Ltd., a company in India that produces and offers services related to 3D printers. The company presents this innovative bioprinter, aimed at creating human tissue, as one of the top bioprinters in its cost category. It possesses the ability to print an extensive array of biomaterials and comes with built-in options for UV curing. Additionally, it is equipped with HEPA filters and temperature regulation, enabling the printhead and the print bed to either be cooled down to 4 degrees Celsius or heated.

What Are the Key Segments in the Bioengineering Technology Market?
The bioengineering technology market covered in this report is segmented -

1) By Product: Biomedical Engineering, Genetic Engineering, Biotechnology, Tissue Engineering, Biomechanics Engineering, Biomaterial, Biomechanical Engineering, Nano-Biotechnology, Bioinformatics, Other Products
2) By Technology: Nanobiotechnology, Tissue Engineering And Regeneration, DNA Sequencing, Cell-Based Assays, Fermentation
3) By Application: Health, Food And Agriculture, Natural Resources And Environment

Subsegmnets:
1) By Biomedical Engineering: Medical Devices, Diagnostic Equipment, Prosthetics And Implants
2) By Genetic Engineering: Gene Editing Tools (CRISPR), Recombinant DNA Technology, Gene Therapy Products
3) By Biotechnology: Biopharmaceuticals, Industrial Biotechnology Products, Agricultural Biotechnology
4) By Tissue Engineering: Scaffolds, Stem Cell Technology, Regenerative Medicine Products
5) By Biomechanics Engineering: Motion Analysis Systems, Orthopedic Biomechanics, Sports Biomechanics Products
6) By Biomaterials: Natural Biomaterials, Synthetic Biomaterials, Biodegradable Polymers
7) By Biomechanical Engineering: Prosthetic Devices, Orthotic Devices, Rehabilitation Equipment
8) By Nano-Biotechnology: Nanoparticles For Drug Delivery, Nanosensors, Nanomaterials For Biomedical Applications
9) By Bioinformatics: Genomic Data Analysis Tools, Protein Structure Analysis Software, Biological Databases
10) By Other Products: Environmental Bioengineering Solutions, Bioremediation Technologies, Bioprocessing Equipment

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13609&type=smp

Who Are the Key Players Shaping the Bioengineering Technology Market's Competitive Landscape?
Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca PLC, Medtronic PLC, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton inson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc., Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics

What Geographic Markets Are Powering Growth in the Bioengineering Technology Market?
North America was the largest region in the bioengineering technology market in 2024. The regions covered in the bioengineering technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13609

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.